Katarina Sevcikova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Approximately 20%-25% of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor. This overexpression is associated with aggressive disease, relatively poor prognosis, and worse clinical outcomes. Neoadjuvant therapy is the standard treatment in patients(More)
  • 1